+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

OTC Drug and Dietary Supplement Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Type; Form; Distribution Channel, and Geography

  • PDF Icon

    Report

  • 200 Pages
  • August 2020
  • Region: Global
  • The Insight Partners
  • ID: 5145012
UP TO OFF until Jun 30th 2024
OTC Drug and Dietary Supplement Market for Analgesics and Cough and Cold Productsto Grow at Highest CAGR During 2020-2027

According to our new market research study on OTC drug and dietary supplement Market to 2027 - Global Analysis and Forecast - by Product, Type, Form, Distribution Channel the market is expected to reach US$ 4, 92,102.49 million by 2027 from US$ 2, 93,255.40 million in 2019. The market is estimated to grow with a CAGR of 6.8 % from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Based on the product, the OTC drug and dietary supplement market is segmented into the analgesics, cough and cold products, vitamins and dietary supplements, gastrointestinal products, antacids, ophthalmic products, sleep aids, oral care products, feminine care, and others. In 2019, the analgesics segment accounted for the highest share of the market. The growth of the segment is attributed to the highest sale of generic painkillers across the world. The sales of analgesics are widely made for acute and chronic pains. It does not require a prescription and easily available through different distribution channels. Additionally, the segment has received several product approvals in the market.

GlaxoSmithKline plc.; Sanofi; Johnson and Johnson Services, Inc.; Abbott; AbbVie Inc.; Bausch Health Companies Inc.; Bayer AG; Procter & Gamble; Novartis AG; and Reckitt Benckiser Group Plc.are among the leading companies operating in the OTC drug and dietary supplement market.

The report segments global OTC drug and dietary supplement market as follows:

By Product
  • Cough and Cold Products
  • Vitamins and Dietary Supplements
  • Analgesics
  • Gastrointestinal Products
  • Sleep Aids
  • Oral Care Products
  • Ophthalmic Products
  • Antacids
  • Feminine Care
  • Others

By Type
  • Branded
  • Generic

By Form
  • Tablets
  • Capsules
  • Powders
  • Ointments
  • Liquid
  • Others

By Distribution Channel
  • Hospital and Retail Pharmacies
  • Retail Stores
  • Online Channels
  • Others

By Geography
  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Middle East and Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • South and Central America (SCAM)
  • Brazil
  • Argentina

Reasons to Buy:
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the OTC drug and dietary supplement market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global OTC drug and dietary supplement market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 OTC drug and Dietary Supplement- By Product
1.3.2 OTC Drug and Dietary Supplement- By Type
1.3.3 OTC Drug and Dietary Supplement- By Form
1.3.4 OTC Drug and Dietary Supplement - By Distribution Channel
1.3.5 Global OTC Drug and Dietary Supplement- By Geography
2. OTC Drug and Dietary Supplement - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global OTC Drug And Dietary Supplement- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. OTC Drug and Dietary Supplement - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Awareness Regarding General Health Issues
5.1.2 Growing Preference for Non-Prescription Drugs over Prescription Drugs
5.2 Market Restraints
5.2.1 Stringent FDA Regulations Related to Safety and Efficacy of OTC Drugs
5.3 Market Opportunities
5.3.1 R&D Activities by Market Players to Offer Improved OTC Drugs
5.4 Future Trends
5.4.1 Selection of OTC Drugs for Minor Diseases
5.5 Impact Analysis
6. OTC Drug and Dietary Supplement - Global Analysis
6.1 Global OTC Drug and Dietary Supplement Revenue Forecast And Analysis
6.2 Global OTC Drug and Dietary Supplement, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. OTC Drug and Dietary Supplement Analysis - By Product
7.1 Overview
7.2 OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
7.3 Cough and Cold Products
7.3.1 Overview
7.3.2 Cough and Cold Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.4 Vitamins and Dietary Supplements
7.4.1 Overview
7.4.2 Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesics
7.5.1 Overview
7.5.2 Analgesics: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.6 Gastrointestinal Products
7.6.1 Overview
7.6.2 Gastrointestinal Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.7 Sleep Aids
7.7.1 Overview
7.7.2 Sleep Aids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.8 Oral Care Products
7.8.1 Overview
7.8.2 Oral Care Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.9 Ophthalmic Products
7.9.1 Overview
7.9.2 Ophthalmic Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.10 Antacids
7.10.1 Overview
7.10.2 Antacids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.11 Feminine Care
7.11.1 Overview
7.11.2 Feminine Care: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
8. OTC Drug and Dietary Supplement Analysis - By Type
8.1 Overview
8.2 OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
8.4 Generic
8.4.1 Overview
8.4.2 Generic: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9. OTC Drug and Dietary Supplement Analysis - By Form
9.1 Overview
9.2 OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)
9.3 Tablets
9.3.1 Overview
9.3.2 Tablets: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.4 Capsules
9.4.1 Overview
9.4.2 Capsules: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.5 Powders
9.5.1 Overview
9.5.2 Powders: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.6 Ointments
9.6.1 Overview
9.6.2 Ointments: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.7 Liquid
9.7.1 Overview
9.7.2 Liquid: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10. OTC Drug and Dietary Supplement Analysis - By Distribution Channel
10.1 Overview
10.2 OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)
10.3 Hospital and Retail Pharmacies
10.3.1 Overview
10.3.2 Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Stores
10.4.1 Overview
10.4.2 Retail Stores: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
11. OTC Drug and Dietary Supplement Analysis And Forecasts To 2027 - Geographical Analysis
11.1 North America: OTC Drug and Dietary Supplement Market
11.1.1 Overview
11.1.2 North America: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.4 North America: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.5 North America: OTC Drug and Dietary Supplement Market, By Form - Revenue and Forecast to 2027 (USD Million)
11.1.6 North America: OTC Drug and Dietary Supplement Market, By Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.7 North America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.1.8 US: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.8.3 US: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.8.4 US: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.8.5 US: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.9 Canada: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Canada: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Canada: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Canada: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.10 Mexico: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.10.3 Mexico: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.10.4 Mexico: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.10.5 Mexico: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.2 Europe: OTC Drug and Dietary Supplement Market
11.2.1 Overview
11.2.2 Europe: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.2.4 Europe: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.2.5 Europe: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.2.6 Europe: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.2.7 Europe: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.2.8 Germany: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.2.8.3 Germany: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.2.8.4 Germany: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.2.8.5 Germany: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.2.9 France: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.9.1 France: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.9.2 France: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.2.9.3 France: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.2.9.4 France: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.2.9.5 France: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.2.10 UK: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.10.1 UK: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.10.2 UK: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.2.10.3 UK: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.2.10.4 UK: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.2.10.5 UK: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.2.11 Italy: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Italy: OTC Drug and Dietary Supplement Market,- Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Italy: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.2.11.3 Italy: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.2.11.4 Italy: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.2.11.5 Italy: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.2.12 Spain: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Spain: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Spain: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.2.12.3 Spain: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.2.12.4 Spain: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.2.12.5 Spain: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.3 Asia-Pacific: OTC Drug and Dietary Supplement Market
11.3.1 Overview
11.3.2 Asia-Pacific: OTC Drug and Dietary Supplement Market,- Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.3.4 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.3.5 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.3.6 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.3.7 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.3.8 China: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: OTC Drug and Dietary Supplement Market,, by Product - Revenue and Forecast to 2027 (USD Million)
11.3.8.3 China: OTC Drug and Dietary Supplement Market,, by Type - Revenue and Forecast to 2027 (USD Million)
11.3.8.4 China: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.3.8.5 China: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.3.9 Japan: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.3.9.3 Japan: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.3.9.4 Japan: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.3.9.5 Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.3.10 India: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.3.10.3 India: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.3.10.4 India: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.3.10.5 India: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.3.11 South Korea: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.3.11.3 South Korea: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.3.11.4 South Korea: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.3.11.5 South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.3.12 Australia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Australia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.2 Australia: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.3.12.3 Australia: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.3.12.4 Australia: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.3.12.5 Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.4 Middle East & Africa: OTC Drug and Dietary Supplement Market
11.4.1 Overview
11.4.2 Middle East & Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (US$ Million)
11.4.3 Middle East & Africa OTC Drug and Dietary Supplement Market, by Product- Revenue and Forecast to 2027 (USD Million)
11.4.4 Middle East & Africa OTC Drug and Dietary Supplement Market, by Type- Revenue and Forecast to 2027 (USD Million)
11.4.5 Middle East & Africa OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.4.6 Middle East & Africa OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.4.7 Middle East & Africa: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.4.8 Saudi Arabia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.4.8.3 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.4.8.4 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
11.4.8.5 Saudi Arabia: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
11.4.9 UAE: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: OTC Drug and Dietary Supplement Market, by Product- Revenue and Forecast to 2027 (USD Million)
11.4.9.3 UAE: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.4.9.4 UAE: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
11.4.9.5 UAE: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.4.10 South Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.4.10.1 South Africa: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.4.10.3 South Africa: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.4.10.4 South Africa: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
11.4.10.5 South Africa: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
11.5 South and Central America: OTC Drug and Dietary Supplement Market
11.5.1 Overview
11.5.2 South and Central America: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.5.3 South and Central America: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.5.4 South and Central America: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.5.5 South and Central America: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
11.5.6 South and Central America: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
11.5.7 South and Central America: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.5.8 Brazil: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.5.8.3 Brazil: OTC Drug and Dietary Supplement Market, by Type- Revenue and Forecast to 2027 (USD Million)
11.5.8.4 Brazil: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
11.5.8.5 Brazil: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.5.9 Argentina: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.5.9.3 Argentina: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.5.9.4 Argentina: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027(USD Million)
11.5.9.5 Argentina: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027(USD Million)
12. Impact of COVID-19 Pandemic on Global OTC Drug And Dietary Supplement Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. OTC Drug and Dietary Supplement Market- Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. COMPANY PROFILES
14.1 GlaxoSmithKline plc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Sanofi
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Johnson and Johnson Services, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Abbott
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 AbbVie Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Bausch Health Companies Inc.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Bayer AG
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Procter & Gamble
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Novartis AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Reckitt Benckiser Group Plc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary of Terms

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • GlaxoSmithKline plc.
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Abbott
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Procter & Gamble
  • Novartis AG
  • Reckitt Benckiser Group Plc